Pliant Therapeutics, Inc. Common Stock

PLRXNASDAQ • USD
0.67 USD
↘ 0.03 (3.92%)🟢LIVE (AS OF 02:25 PM EST)
🟢Market: OPEN

Pliant Therapeutics, Inc. Common Stock (PLRX) trades at $0.67 per share. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.

Technical & fundamental data as of Nov 16, 2026.

Open?$0.70
High?$0.72
Low?$0.66
Prev. Close?$0.69
Volume?537.5K
Avg. Volume?396.0K
VWAP?$0.68
Rel. Volume?1.36x
Bid / Ask
Bid?$0.57 × 100
Ask?$0.77 × 100
Spread?$0.20
Midpoint?$0.67
Valuation & Ratios
Market Cap?42.8M
Shares Out?61.9M
Float?50.4M
Float %?81.3%
P/E Ratio?N/A
P/B Ratio?0.34
EPS?-$1.46
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Employees
49
Market Cap
43.2M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2020-06-03
Address
331 OYSTER POINT BOULEVARD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-481-6770
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
0
Momentum?
50
Short Sent.?
43
Piotroski F-Score?0/9Weak
Altman Z-Score?-7.99Distress
Confidence?54%Low
Full Fundamental Analysis →
Short InterestVery High
Short % of Float?9.69%Elevated
Short Interest?4.9M
Days to Cover?16.2
Free Float50.4M
Avg Daily Volume301.4K
Settlement Date2026-10-30
Financial Health
Current Ratio?8.05Strong
Quick Ratio?8.05Strong
Cash Ratio?1.48Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.34CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-0.2CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-71.4%WEAK▾
ROA?
S&P
3
-53.2%WEAK▾
Cash Flow & Enterprise
FCF?$-66789000
Enterprise Value?$16.2M
Fundamentals ratios updated end of day